Key result
HFpEF carries 8-12% annual mortality and is managed via lifestyle changes, diuretics, and comorbidity treatment.
Provides a general overview of the diagnosis and management of heart failure with preserved ejection fraction, emphasizing lifestyle modifications, symptom control, and comorbidity management.
Supports supportive HFpEF care; leaves open targeted therapies to improve survival.
Nearly six million people in United States have heart failure. Fifty percent of these people have normal left ventricular (LV) systolic heart function but abnormal diastolic function due to increased LV myocardial stiffness. Most commonly, these patients are elderly women with hypertension, ischemic heart disease, atrial fibrillation, obesity, diabetes mellitus, renal disease, or obstructive lung disease. The annual mortality rate of these patients is 8%-12% per year. The diagnosis is based on the history, physical examination, laboratory data, echocardiography, and, when necessary, by cardiac catheterization. Patients with obesity, hypertension, atrial fibrillation, and volume overload require weight reduction, an exercise program, aggressive control of blood pressure and heart rate, and diuretics. Miniature devices inserted into patients for pulmonary artery pressure monitoring provide early warning of increased pulmonary pressure and congestion. If significant coronary heart disease is present, coronary revascularization should be considered.
No takes yet. Share an insight, caveat, or question.
Robert J. Henning (2019) conducted a review in Heart failure with preserved left ventricular ejection fraction. Heart failure with preserved ejection fraction has an annual mortality rate of 8%-12% and is managed through weight reduction, exercise, blood pressure control, diuretics, and comorbidity treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: